B

FHLC — Fidelity MSCI Health Care Index ETF

Healthcare   Ranked #86 of 458 tracked ETFs   ·   Issued by Fidelity Investments

71.7/100
$81.00
0.084%
$3.22B
+26.80%
1.32%
Moderate
1.42
-16.87%
0.57
11.40%
209K/day

FHLC Price Performance — Growth of $10,000

Value of a $10,000 investment in FHLC over time, compared with SPY. Both lines are rebased to $10,000 on the first shared date. Based on total returns — prices are adjusted for dividends and splits, so this assumes distributions were reinvested. Hover or tap the chart for exact values.

FHLC Drawdown

The "underwater" chart: FHLC's decline from its highest prior value at each point in time. It shows how deep past losses ran and how long the fund took to recover to break-even.

What If You'd Invested in FHLC?

See what a lump sum in FHLC would have grown to, with the option to add a regular monthly contribution on top. Figures use total returns — dividends are assumed reinvested.

Jump to:
Loading price history…

Past performance doesn't predict future results. Assumes contributions on the first trading day of each month, no trading costs or taxes, and reinvested distributions. History is limited to the range published in the site's daily return data.

Overview

The Fidelity MSCI Health Care Index ETF (FHLC) is a Healthcare sector fund managed by Fidelity Investments with $3.22 billion in assets under management. It holds an overall rank of #86 out of 458 tracked ETFs across all categories and has received an ETFValuer grade of B with a score of 71.7/100. The fund charges an expense ratio of 0.084% and offers a dividend yield of 1.32%. Trading at a price of $81.00, the fund's substantial asset base suggests significant investor adoption within the 11 ETFs tracked in the Healthcare category. This combination of low cost and moderate income profile positions the fund as a widely utilized vehicle for sector exposure. The high asset count relative to the category size indicates it is a central holding for many investors seeking healthcare sector participation.

Short-term returns show strong momentum with a 1-day gain of +2.20% and a 1-week increase of +3.81%. The 1-month return of +4.02% continues this upward trajectory, while the 3-month period reflects a significant acceleration to +17.07%. Over the half-year mark, the fund posted a +7.56% return, and year-to-date performance stands at +9.39%. The 1-year return reached +26.80%, and the 3-year return totals +33.58%, indicating sustained growth over the longer term. This pattern demonstrates a consistent positive trend across all measured horizons from daily performance through the three-year period.

The fund carries a Moderate volatility label and a beta of 0.57, suggesting it moves less than the broader market. A Sharpe ratio of 1.42 indicates that the returns generated per unit of risk taken are relatively high. The maximum drawdown of -16.87% represents the largest peak-to-trough decline experienced during the measurement period. This combination of low beta and high Sharpe ratio implies the fund has provided efficient returns with limited downside relative to its peers. The moderate volatility and specific drawdown figure suggest a balanced risk profile that has managed market fluctuations effectively while delivering positive returns.

AI-generated summary based on the data on this page.

FHLC Top Holdings

#Holding% of Net AssetsValue
1 Eli Lilly & Co 12.13% $346M
2 Johnson & Johnson 8.94% $255M
3 AbbVie Inc 6.03% $172M
4 UnitedHealth Group Inc 5.42% $155M
5 Merck & Co Inc 4.38% $125M
6 Amgen Inc 3.01% $86M
7 Thermo Fisher Scientific Inc 2.91% $83M
8 Gilead Sciences Inc 2.62% $75M
9 Intuitive Surgical Inc 2.62% $75M
10 Abbott Laboratories 2.55% $73M

Holdings as of 2026-04-30 per the fund's most recent SEC N-PORT-P filing. Top 10 holdings make up 50.6% of net assets — a rough gauge of concentration risk (the higher this figure, the more the fund's return depends on a handful of names). To see how FHLC's holdings overlap with other ETFs you own or are considering, check the Stock Overlap tool.

Which Funds Overlap With FHLC

Holding two funds that own the same companies adds cost and complexity without adding much diversification. These tracked ETFs share the most names with FHLC's top 10 — VHT overlaps most, holding 10 of the same companies as FHLC's top 10 (50.6% of FHLC's assets).

ETFNameShared CompaniesFHLC WeightExamples
VHT Vanguard Health Care Index Fund ETF Shares 10 50.6% Eli Lilly & Co, Johnson & Johnson, AbbVie Inc…
XLV State Street Health Care Select Sector SPDR ETF 10 50.6% Eli Lilly & Co, Johnson & Johnson, AbbVie Inc…
IYH iShares U.S. Healthcare ETF 9 38.5% Johnson & Johnson, AbbVie Inc, UnitedHealth Group Inc…
PPH VanEck Pharmaceutical ETF 3 25.4% Eli Lilly & Co, Merck & Co Inc, Johnson & Johnson
DGRO iShares Core Dividend Growth ETF 3 20.4% Johnson & Johnson, AbbVie Inc, UnitedHealth Group Inc

Compares the top 10 reported holdings of each fund, so it's a floor on true overlap — two S&P 500 trackers overlap ~100% even when only 10 names are listed. Use the Stock Overlap tool to search by individual company.

Market Backdrop

4.65%
18.67
3.63%

10-Year Treasury Yield: 4.65% (as of 2026-07-27) — The yield on 10-year US Treasury bonds — the standard "risk-free rate" benchmark used to contextualize this fund’s Sharpe ratio and returns.

CBOE Volatility Index (VIX): 18.67 (as of 2026-07-27) — A real-time gauge of expected S&P 500 volatility over the next 30 days — useful context for this fund’s own volatility label.

Federal Funds Rate: 3.63% (as of 2026-06-01) — The Federal Reserve’s target policy rate, which anchors short-term borrowing costs across the economy.

What FHLC's Fees Cost You

FHLC charges an expense ratio of 0.08% a year, deducted automatically from the fund's value. Small percentages compound into real money — adjust the figures below to see the impact on your own numbers.

$46,609.57
$45,889.87
$719.71
Cheaper alternative in this category: XLV charges 0.08% vs FHLC's 0.08%. On the figures above you'd keep $34.03 more over 20 years — same assumed 8% gross return, fee difference only.

Assumes a constant gross return and no additional contributions — a simplification, but it isolates exactly what the expense ratio costs. Try the full fee calculator to model contributions and compare any two funds.

FHLC Dividend Income Estimator

FHLC currently yields 1.32%. Enter an amount to see the income that implies, or set a monthly income target to see the investment it would take.

$132.00
$11.00
$2.54

Based on the fund's current trailing yield, which varies with price and distributions — treat it as an estimate, not a guarantee. Yields are not adjusted for tax.

FHLC Liquidity, Domicile & Tax Treatment

Liquidity: Quoted bid/ask spread is 11.40% and average daily volume is 209K/day. Tighter spreads and higher volume mean lower round-trip trading costs; this is a live-market snapshot and can widen during volatile sessions. AUM of $3.22B provides ample scale, supporting tight spreads and issuer commitment to keep the fund open.

Domicile & tax treatment: FHLC is a US-domiciled, SEC-registered ('40 Act) exchange-traded fund. Dividends and capital gains distributions are reported to US investors on Form 1099-DIV, and the fund is not subject to the PFIC reporting or UCITS-specific rules that apply to Irish- or Luxembourg-domiciled funds. Non-US investors should note that US-domiciled ETFs are generally subject to 30% US withholding tax on dividends (unless reduced by treaty) and to US estate tax exposure on the position — Irish-domiciled UCITS ETFs tracking the same index often avoid both, which is why non-US residents frequently prefer the UCITS equivalent where one exists. This is general information, not tax advice — consult a tax professional for your situation.

FHLC Performance History

PeriodReturn
1-Day+2.20%
1-Week+3.81%
1-Month+4.02%
3-Month+17.07%
6-Month+7.56%
YTD+9.39%
1-Year+26.80%
3-Year+33.58%

How FHLC Compares to Other Healthcare ETFs

RankGradeTickerName1-YearExp. RatioAUM
#50
B
VHT Vanguard Health Care Index Fund ETF Shares +26.69% 0.09% $20.4B
#58
B
XLV State Street Health Care Select Sector SPDR ETF +24.69% 0.08% $40.6B
#60
B
XBI State Street SPDR S&P Biotech ETF +71.74% 0.35% $10.7B
#86
B
FHLC Fidelity MSCI Health Care Index ETF +26.80% 0.084% $3.22B
#107
B
IBB iShares Biotechnology ETF +40.96% 0.44% $9.09B
#112
B
XPH State Street SPDR S&P Pharmaceuticals ETF +60.44% 0.35% $428M
#146
B
PPH VanEck Pharmaceutical ETF +29.37% 0.36% $879M
#167
B
IYH iShares U.S. Healthcare ETF +24.12% 0.38% $3.16B
#232
C
IHF iShares U.S. Healthcare Providers ETF +37.30% 0.38% $1.18B
#383
D
ARKG ARK Genomic Revolution ETF +45.46% 0.75% $1.73B
#443
F
IHI iShares U.S. Medical Devices ETF -13.86% 0.38% $3.02B
How FHLC's grade is calculated. ETFValuer scores every ETF on the same six-factor formula — returns, Sharpe ratio, expense ratio, max drawdown, fund size, and volatility — recalculated daily from live price data. See the full methodology or view FHLC alongside every other tracked fund in the complete rankings table. You can also look up FHLC on Yahoo Finance ↗.